Protocol summary

Summary
Aim: comparing the pain severity after laparoscopic cholecystectomy with intra-peritoneal injection of bupivacaine, morphine, hydrocortisone in 5th Azar hospital, 2016-2017 Design: double blind randomized phase 3 clinical trial, single center Study population: Cases candidate for cholecystectomy by laparoscopic method allocated in 3 groups Inclusion criteria:cases ages 20-50 years old with class I and II ASA Exclusion criteria: Consumption of opioids or sedative before operation, hematologic or neurologic diseases Intervention: intra-peritoneal injection of bupivacaine, morphine, hydrocortisone Intervention time: at the end of operation Outcome measures: Lowering the pain after operation

General information

Acronym
IRCT registration information
IRCT registration number: IRCT201703011264N9
Registration date: 2017-05-27, 1396/03/06
Registration timing: retrospective

Last update:
Update count: 0
Registration date
2017-05-27, 1396/03/06
Registrant information
Name
Sima Besharat
Name of organization / entity
Golestan University of Medical Sciences
Country
Iran (Islamic Republic of)
Phone
+98 17 1224 4170
Email address
besharat@goums.ac.ir
Recruitment status
Recruitment complete
Funding source
Vice chancellor for research, Golestan University of Medical Sciences
Expected recruitment start date
2016-02-20, 1394/12/01
Expected recruitment end date
2017-03-20, 1395/12/30
Actual recruitment start date
empty
Actual recruitment end date
empty
Trial completion date
empty
Scientific title
Comparison of pain severity after intraperitoneal injection of bupivacaine, morphine, hydrocortisone in laparoscopic cholecystectomy
Public title
Comparison of pain severity after intraperitoneal injection of bupivacaine, morphine, hydrocortisone in laparoscopic cholecystectomy
Purpose
Prevention
Inclusion/Exclusion criteria
Inclusion criteria: Patients candidate for laparoscopic cholecystectomy; age between 20 to 50 years; Class I and II ASA Exclusion criteria: Opioid consumption during 24 hours before the operation; Chronic fatigue syndrome; Inability to report pain; Steroid therapy; Neurologic diseases; Taking NSAIDs; Acute cholecystitis; Other kind of cholelithiasis (other than gall bladder); Hematological disorders; Neuromuscular diseases
Age
From 20 years old to 50 years old
Gender
Both
Phase
2-3
Groups that have been masked
No information
Sample size
Target sample size: 60
Randomization (investigator's opinion)
Randomized
Randomization description
Blinding (investigator's opinion)
Double blinded
Blinding description
Placebo
Not used
Assignment
Parallel
Other design features

Secondary Ids

empty

Ethics committees

1

Ethics committee
Name of ethics committee
Golestan University of Medical Sciences
Street address
Falsafi educational complex, 2 km from Gorgan to Sari
City
Gorgan
Postal code
Approval date
2017-05-22, 1396/03/01
Ethics committee reference number
IR.GOUMS.REC.1396.3

Health conditions studied

1

Description of health condition studied
Pain
ICD-10 code
ICD-10 code description

Primary outcomes

1

Description
Pain reduction
Timepoint
Hours 0.5-1-4-8-16 after the surgery
Method of measurement
VAS scale

Secondary outcomes

1

Description
Time of bowel function onset
Timepoint
Hours 6-12-24 after the surgery
Method of measurement
Personal report

2

Description
Nausea and vomiting
Timepoint
Hours 0.5-1-4-8-12-16 after the surger
Method of measurement
Personal report

3

Description
Time of oral nutriton
Timepoint
Hours 6-12-24 after the surgery
Method of measurement
Personal report

4

Description
Time of movement without help
Timepoint
Hours 6-12-24 after the surgery
Method of measurement
Personal report

Intervention groups

1

Description
Intra-peritoneal injection of 30 cc Bupivacaine 0.25%
Category
Treatment - Drugs

2

Description
Intra-peritoneal injection of 30 cc Bupivacaine 0.25% plus 2 milligram Morphine
Category
Treatment - Drugs

3

Description
Intr-peritoneal injection of 200 milligram Hydrocortisone
Category
Treatment - Drugs

Recruitment centers

1

Recruitment center
Name of recruitment center
5th Azar hospital, Gorgan
Full name of responsible person
Dr. Maryam Zahedi Tabarestani
Street address
5th Azar Hospital, 5th Azar St, Gorgan city
City
Gorgan

Sponsors / Funding sources

1

Sponsor
Name of organization / entity
Vice chancellor for research, Golestan University of Medical Sciences
Full name of responsible person
Dr. Hossein Taziki
Street address
Falsafi educational complex, Shastkola road, Gorgan
City
Gorgan
Grant name
Grant code / Reference number
Is the source of funding the same sponsor organization/entity?
Yes
Title of funding source
Vice chancellor for research, Golestan University of Medical Sciences
Proportion provided by this source
100
Public or private sector
empty
Domestic or foreign origin
empty
Category of foreign source of funding
empty
Country of origin
Type of organization providing the funding
empty

Person responsible for general inquiries

Contact
Name of organization / entity
Golestan University of Medical Sciences
Full name of responsible person
Dr.Maryam Zahedi Tabarestani
Position
Assistant of anesthesiology
Other areas of specialty/work
Street address
5th Azar hospital, 5th Azar St, Gorgan
City
Gorgan
Postal code
Phone
+98 17 3242 1660
Fax
Email
maryamzahedi25@yahoo.com
Web page address

Person responsible for scientific inquiries

Contact
Name of organization / entity
Golestan University of Medical Sciences
Full name of responsible person
Dr.Maryam Zahedi Tabarestani
Position
Assistant of anesthesiology
Other areas of specialty/work
Street address
5th Azar hospital, 5th Azar St, Gorgan
City
Gorgan
Postal code
Phone
+98 17 3242 1660
Fax
Email
maryamzahedi25@yahoo.com
Web page address

Person responsible for updating data

Contact
Name of organization / entity
Golestan University of Medical Sciences
Full name of responsible person
Dr.Maryam Zahedi Tabarestani
Position
Assistant of anesthesiology
Other areas of specialty/work
Street address
5th Azar hospital, 5th Azar St, Gorgan
City
Gorgan
Postal code
Phone
+98 17 3242 1660
Fax
Email
Web page address

Sharing plan

Deidentified Individual Participant Data Set (IPD)
empty
Study Protocol
empty
Statistical Analysis Plan
empty
Informed Consent Form
empty
Clinical Study Report
empty
Analytic Code
empty
Data Dictionary
empty
Loading...